BeOne Medicines AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	34,689	19,924	11,706	11,515	14,003	16,530
Market Cap Growth	31.12%	70.20%	1.66%	-17.77%	-15.29%	14.48%
Enterprise Value	31,843	92.18	-315.77	-6,100	-16,768	-29,649
Last Close Price	312.02	179.73	109.69	110.11	134.23	160.99
PE Ratio	72.07	9.35	-	-	-	-
Forward PE	45.97	66.95	76.37	76.37	76.37	76.37
PS Ratio	6.03	0.48	0.40	0.60	1.27	1.80
PB Ratio	7.41	0.59	0.45	0.42	0.41	0.35
P/TBV Ratio	7.61	4.74	3.52	3.30	3.19	2.45
P/FCF Ratio	31.03	2.72	-	-	-	-
P/OCF Ratio	26.92	2.27	-	-	-	-
EV/Sales Ratio	5.55	0.00	-0.01	-0.32	-1.52	-3.23
EV/EBITDA Ratio	38.58	0.02	0.10	0.70	1.25	2.73
EV/EBIT Ratio	46.42	0.03	0.07	0.65	1.20	2.64
EV/FCF Ratio	28.57	0.01	0.06	0.45	1.18	2.44
Debt / Equity Ratio	0.41	0.44	0.32	0.26	0.13	0.11
Debt / EBITDA Ratio	2.46	3.40	-	-	-	-
Debt / FCF Ratio	1.84	2.12	-	-	-	-
Net Debt / Equity Ratio	-0.57	-0.58	-0.46	-0.64	-0.90	-0.97
Net Debt / EBITDA Ratio	-3.28	-4.33	3.90	2.01	2.29	4.25
Net Debt / FCF Ratio	-2.46	-2.70	2.44	1.31	2.16	3.79
Asset Turnover	0.68	0.76	0.65	0.40	0.19	0.17
Inventory Turnover	1.04	1.21	1.30	1.09	1.09	0.99
Quick Ratio	3.16	2.96	1.49	1.96	3.21	4.44
Current Ratio	3.64	3.41	1.80	2.32	3.55	4.76
Return on Equity (ROE)	11.25%	7.46%	-18.77%	-22.26%	-38.11%	-29.15%
Return on Assets (ROA)	6.42%	4.36%	-11.72%	-21.17%	-24.52%	-20.63%
Return on Invested Capital (ROIC)	28.01%	17.11%	-44.83%	-149.36%	-559.02%	-
Return on Capital Employed (ROCE)	10.47%	8.88%	-14.76%	-27.12%	-30.21%	-25.11%
Earnings Yield	1.48%	10.70%	-	-	-	-
FCF Yield	3.22%	36.79%	-	-	-	-
Buyback Yield / Dilution	-8.16%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%
Total Shareholder Return	-8.16%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%

SEC Filings: 10-K · 10-Q